United Neuroscience Ltd.   Report issue

For profit Phase 1 Phase 2
Founded: Dublin Ireland (2014)

Organization Overview

First Clinical Trial
2015
NCT02551809
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

United Neuroscience Ltd.

Active Ingredients

Drugs in Phase 2 Trials (1)

ub-311 (2 trials)

Drugs in Phase 1 Trials (1)

ub-312 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Alzheimer Disease (Phase 2)

Parkinson Disease (Phase 1)

Parkinsonian Disorders (Phase 1)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 3
  • # of Trial APIs: 2